Browse > Article

Effects of Recombinant Human Bone Morphogenetic Protein-2 loaded Acellular Dermal Matrix on Bone Formation  

Song, Dae-Seok (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Tae-Gyun (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Jung, Ui-Won (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Choi, Seong-Ho (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Cho, Kyoo-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Chai, Jung-Kiu (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Chong-Kwan (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Kim, Chang-Sung (Department of periodontology, Research institute for periodontal Regeneration, College of Dentistry, Yonsei University)
Publication Information
Journal of Periodontal and Implant Science / v.37, no.3, 2007 , pp. 511-522 More about this Journal
Abstract
Introduction : The purpose of this study was to evaluate the possibility of the acellular dermal matrix (ADM) as a barrier membrane for bone regeneration, and to evaluate the osteogenic effect of ADM as a carrier system for rhBMP-2 in the rat calvarial defect model. Materials and Methods: An 8-mm, calvarial, critical-size osteotomy defect was created in each of 60 male Spraque-Dawley rats(weight $250{\sim}300g$). Three groups of 20 animals, each received either rhBMP-2(0.025mg/ml) in an ADM carrier, ADM only, or negative surgical control. And each group was divided into 2- and 8-weeks healing intervals. The groups were evaluated by histologic and histomorphometric parameters(10 animals/group/healing intervals). Data were expressed as $means{\pm}standard$ deviations($m{\pm}SD$). Comparisons between experimental and control groups were made using two-way ANOVA and post hoc t-test. Comparisons between 2 weeks and 8 weeks were made using paired t-test. The level of statistical difference was defined as P< 0.05. Results : The ADM group and rhBMP-2/ADM group results in enhanced local bone formation in the rat calvarial defect at both 2 and 8 weeks. The amount of defect closure and new bone formation were significantly greater in the rhBMP-2/ADM group relative to ADM group(P<0.05). At 8 weeks, the majority of ADM in the defect was contracted, and integrated with surrounding host tissues. In addition, host cell infiltration and neovascularization of the ADM in the absence of an inflammatory response were observed, and the newly formed bone around ADM showed a continuous remodeling and consolidation. Conclusion : The results of the present study indicated that ADM may be used as a barrier membrane for bone regeneration and that may be employed as a delivery system for BMPs.
Keywords
recombinant human bone morphogenetic protein-2; a barrier membrane; Acellular dermal matrix; rat calvarial defect model;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Celeste AJ. Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor-family members present in bone-inductive protein purified from bovine bone, Proc Natl Acad Sci USA 1990;87:9843-7
2 Aldinger G, Herr G, Kusserwetter W, et al Bone morphogenetic protein: a review. Int Orthop 1991;15: 169-177   PUBMED
3 Shulman J. Clinical evaluation of an acellular dermal allograft for increasing the zone of attached gingiva. Pract Periodontics Aesthet Dent. 1996 Mar:8(2): 201-8   PUBMED
4 King GN, Cochran DL. Factors that modulate the effect of bone morphogenetic protein-in-: duced periodontal regeneration: a critical review, J Pcriodontol 2002;73:925-936   DOI   ScienceOn
5 Sampath TK, Maliakal JC, Hauschka PV, et al, Recombinant human osteo-genic pro-tein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992:267:20352-62   PUBMED
6 Wang EA, Rosen V, D'Alessandro JS, et al Recombinant human bone morphogenetic protein induces bone formation Proc Natl Acad Sci USA 1990:87:2220-4
7 McFeely WJ. Bojrab DI, Kartush JM. Tympanic membrane perforation using Alloderm. Otolaryngol Head Neck Surg 2000; 123:17-21   DOI   ScienceOn
8 Wei PC, Laurell L. Lingen MW, Gcivelis M, Acellular dermal matrix allografts to achieve increased attached gingiva, Part 2. A histological comparative study. J Periodontol 2002 Mar:73(3):257-65   DOI   ScienceOn
9 Schmitz JP, Hollinger JO, The critical size defect as an experimental model for craniomandibulofacial nonunion. Clin Orthop 1986;205: 299-308
10 Kim CS, Choi SH, Choi BK, et al The effect of recombinant human bone morphogenetic protoin-4 on the osteoblastic differcntiation of mouse calvarial cells affected by Porphyromonas gingivalis, J Periodontol 2002; 73:1126-1132   DOI   ScienceOn
11 Pang EK, Im SU, Kim CS, et al, Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defects. J Periodontol 2004:75: 1364-1370   DOI   ScienceOn
12 Livesey S. Herndon D, Hollyoak M, Atkinson Y, Nag A. Transplanted acellular allograft dermal matrix. Transplantation 1995:60: 1-9   DOI
13 Urist MR, Lietzo A, Dawson E, Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984; 187:277-280
14 Urist MR. Bone formation by autoinduction, Science 1965:150:893-899   DOI   ScienceOn
15 Hyun SJ, Choi SH, Chai JK et al The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects, J Periodontol 2005:76:1-8   DOI   ScienceOn
16 Yasco AW, Lane JM, Fellinger EJ. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2), J Bone Joint Surg 1992;74-A: 659-671
17 Ahn SH, Kim CS. Suk HJ, et al Effect of Recombinant Human Bone Morphogenetic Protein- 4 with Carriers in Rat Calvarial Defects. J Periodontol 2003:74:787-797   DOI   ScienceOn
18 Hong SJ, Kim CS, Jung UW, et al, Fibrin-Fibronectin Sealing System in Combination with -Tricalcium Phosphate as a Carrier for Recombinant Human Bone Morphogenetic Protein-2: Effects on Bone Formation in Rat Calvarial Defects Biomaterials 2005 accepted for publication
19 Harris RJ, Soft tissue ridge augmentation with an acellular dermal matrix Int J Periodontics Restorative Dent. 2003 Feb: 23(1): 87-92   PUBMED
20 Solloway MJ, Dudley AT, Bikoff EK, et al. Mice lacking BMF-6 function, Dev Genet 1998;22:321-3   DOI   ScienceOn
21 Achauer BM, VanderKam VM, Cclikoz B. Jacobson DC. Augmentation of facial soft tissue defects with Alloderm dermal graft. Ann Plast Surg 1998;41:503-507   DOI
22 Kim CS, Kim JI, Kim J, et al, Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers, Biomaterials 2001:19:1-7
23 Wikesjo UM, Guglielmoni P, Promsudthi A et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontal 1999;26:392-40   DOI   ScienceOn
24 Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF superfamily. Cell 1992;71:399-410   DOI   ScienceOn
25 Novaes AB Jr, Souza SL, Acellular dermal matrix graft as a membrane for guided bone regeneration: a case report. Implant Dent. 2001: 10(3): 192-6   DOI   PUBMED   ScienceOn
26 Wainwright D, Madden M, Luteman A, et al Clinical evaluation of an acellular allograft dermal matrix in full thickness burns, J Burn Care Rehabil 1996:17:124-126   DOI
27 Han DK, Kim CS, Cho KS, Effect of a Fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005 accepted for publication
28 Barboza EP, Duarte ME, Geolas L, et al. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000: 71 :488-496   DOI   ScienceOn
29 Harris RJ. A short-term and long-term comparison of root coverage with an acellular dermal matrix and a subepithelial graft, J Periodontal. 2004 May;75(5):734-43   DOI   ScienceOn
30 Choi SH, Kim CK, Cho KS, et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72   DOI   ScienceOn
31 Kawamura M and Urist MR, Human fibrin is a physiologic delivery system for bone morphogenetic protein, Clin Orthop Rel Res 1988;235:302-310
32 Jena N, Martin-Seisdedos C, McCue P, et al BMF7 null mutation in mice: Developmental defects in skeleton, kidney, and eye. Exp Cell Res 1997:230
33 Tal H. Moses O. Zohar R, Meir H. Nemcovsky C. Root coverage of advanced gingival recession: a comparative study between acellular dermal matrix allograft and subepithelial connective tissue grafts, J Periodontol 2002 Dec:73(12) :1405-11   DOI   ScienceOn
34 Callan DP, Silverstein LB. Use of acellular dermal matrix for increasing keratinized tissue around teeth and implants. Pract Periodontics Aesthet Dent 1998: 10: 731-734   PUBMED
35 Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of fullthickness burns. Burns 1995 Jun:21(4):243-8,   DOI   ScienceOn
36 Wozney JM, Rosen V, Ceel este AJ, et al Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534   DOI
37 Rubin PA, Fay AM, Remulla HD, Maus M. Opthalmic plastic applications of acellular dermal allografts. Ophthalmology 1999;160: 2091-2097
38 Takagi K, Urist MR, The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defect, Ann Surg 1982;196:100-109   DOI   PUBMED   ScienceOn
39 Miki T, Imai Y, Osteoinductive potential of freeze-derived, biodegredable. poly(glycolic acid-co-lactic acid) disks incorporated with bone morphogenetic protein in skull defects in rats J Oral Maxillofac Surg 1996:25:402-426   DOI   ScienceOn
40 Luczyszyn SM, Papalexiou V, Novaes AB Jr, et al, Acellular dermal matrix and hydroxyapatite in prevention of ridge deformities after tooth extraction. Implant Dent. 2005 Jun;14(2):176-84   DOI   ScienceOn